| ESA Therapy for Kidney Patients: Is It Ever Safe? - Medscape |
|
|
Medscape I am Editor-in-Chief of Medscape Nephrology. It has been an interesting week for erythropoietin-stimulating agent (ESA) therapy in patients with chronic kidney disease (CKD) and dialysis. I hope everyone has seen the US Food and Drug Administration |